Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Alzheimer's Research & Therapy
Published in: Alzheimer's Research & Therapy 1/2018

Open Access 01-12-2018 | Research

Neurophysiological signals as predictive translational biomarkers for Alzheimer’s disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats

Authors: Milan Stoiljkovic, Craig Kelley, Tamas L. Horvath, Mihály Hajós

Published in: Alzheimer's Research & Therapy | Issue 1/2018

Login to get access

Abstract

Background

Translational research in Alzheimer’s disease (AD) pathology provides evidence that accumulation of amyloid-β and hyperphosphorylated tau, neuropathological hallmarks of AD, is associated with complex disturbances in synaptic and neuronal function leading to oscillatory abnormalities in the neuronal networks that support memory and cognition. Accordingly, our recent study on transgenic TgF344-AD rats modeling AD showed an age-dependent reduction of stimulation-induced oscillations in the hippocampus, and disrupted long-range connectivity together with enhanced neuronal excitability in the cortex, reflected in greatly increased expression of high-voltage spindles, an epileptic absence seizure-like activity. To better understand the translational value of observed oscillatory abnormalities in these rats, we examine here the effects of donepezil, an acetylcholine esterase inhibitor clinically approved for AD treatment.

Methods

Brainstem nucleus pontis oralis stimulation-induced hippocampal oscillations were recorded under urethane anesthesia in adult (6-month-old) and aged (12-month-old) TgF344-AD and wild-type rats. Spontaneous cortical activity was monitored in a cohort of freely behaving aged rats implanted with frontal and occipital cortical electroencephalography (EEG) electrodes.

Results

Subcutaneous administration of donepezil significantly augmented stimulation-induced hippocampal theta oscillation in aged wild-type rats and both adult and aged TgF344-AD rats, which have been previously shown to have diminished response to nucleus pontis oralis stimulation. Moreover, in adult TgF344-AD rats, donepezil also significantly increased theta phase-gamma amplitude coupling in the hippocampus during stimulation. However, neither of these effects were significantly changed in adult wild-type rats. Under freely behaving conditions, donepezil treatment had the opposite effect on cortical oscillatory connectivity in TgF344-AD and wild-type rats, and it reduced the occurrence of high-voltage spindle activity in TgF344-AD rats.

Conclusions

Together, these results imply that pharmacologically enhancing cholinergic tone with donepezil could partially reverse oscillatory abnormalities in TgF344-AD rats, which is in line with its clinical effectiveness in AD patients. Therefore, our study suggests good translational opportunities for these neurophysiological signals recorded in TgF344-AD rats, and their application could be considered in drug discovery efforts for developing therapies with disease-modifying potential.
Literature
1.
Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2017. Alzheimers Dement (N Y). 2017;3:367–84.
2.
Drummond E, Wisniewski T. Alzheimer's disease: experimental models and reality. Acta Neuropathol. 2017;133:155–75.CrossRefPubMed
3.
Pankevich DE, Wizemann TM, Altevogt BM. Improving the utility and translation of animal models for nervous system disorders: workshop summary. Washington (DC): The National Academies Press; 2013.
4.
Drinkenburg WH, Ruigt GS, Ahnaou A. Pharmaco-EEG studies in animals: an overview of contemporary translational applications. Neuropsychobiology. 2015;72:151–64.CrossRefPubMed
5.
Leiser SC, Dunlop J, Bowlby MR, Devilbiss DM. Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol. 2011;81:1408–21.CrossRefPubMed
6.
Buzsáki G. Theta oscillations in the hippocampus. Neuron. 2002;33:325–40.CrossRef
7.
Cornwell BR, Arkin N, Overstreet C, Carver FW, Grillon C. Distinct contributions of human hippocampal theta to spatial cognition and anxiety. Hippocampus. 2012;22:1848–59.CrossRefPubMedPubMedCentral
8.
Lega BC, Jacobs J, Kahana M. Human hippocampal theta oscillations and the formation of episodic memories. Hippocampus. 2012;22:748–61.CrossRefPubMed
9.
10.
Babiloni C, Del Percio C, Lizio R, Noce G, Cordone S, Lopez S, et al. Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study. Neurobiol Aging. 2017;55:143–58.CrossRefPubMed
11.
Rodriguez G, Copello F, Vitali P, Perego G, Nobili F. EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol. 1999;110:1831–7.CrossRefPubMed
12.
Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708–21.CrossRefPubMedPubMedCentral
13.
14.
Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I, et al. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric abeta, and frank neuronal loss. J Neurosci. 2013;33:6245–56.CrossRefPubMedPubMedCentral
15.
Munoz-Moreno E, Tudela R, Lopez-Gil X, Soria G. Early brain connectivity alterations and cognitive impairment in a rat model of Alzheimer's disease. Alzheimers Res Ther. 2018;10:16.CrossRefPubMedPubMedCentral
16.
Uhlhaas PJ, Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron. 2006;52:155–68.CrossRefPubMed
17.
Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease. Ann Neurol. 2016;80:858–70.CrossRefPubMedPubMedCentral
18.
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Fourth edition. San Diego: Academic Press; 1998.
19.
20.
Stoiljkovic M, Kelley C, Hajós GP, Nagy D, Koenig G, Leventhal L, et al. Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β overproducing transgenic mice. Neurobiol Aging. 2016;45:161–8.CrossRefPubMed
21.
Tort AB, Komorowski RW, Manns JR, Kopell NJ, Eichenbaum H. Theta-gamma coupling increases during the learning of item-context associations. Proc Natl Acad Sci U S A. 2009;106:20942–7.CrossRefPubMedPubMedCentral
22.
Lachaux JP, Rodriguez E, Martinerie J, Varela FJ. Measuring phase synchrony in brain signals. Hum Brain Mapp. 1999;8:194–208.CrossRefPubMed
23.
Mormann F, Lehnertz K, David P, Christian E, Elger CE. Mean phase coherence as a measure for phase synchronization and its application to the EEG of epilepsy patients. Physica D. 2000;144:358–69.CrossRef
24.
Scott L, Feng J, Kiss T, Needle E, Atchison K, Kawabe TT, et al. Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice. Neurobiol Aging. 2012;33:1481 e13–23.CrossRef
25.
Scott L, Kiss T, Kawabe TT, Hajós M. Neuronal network activity in the hippocampus of tau transgenic (Tg4510) mice. Neurobiol Aging. 2016;37:66–73.CrossRefPubMed
26.
Stoiljkovic M, Leventhal L, Chen A, Chen T, Driscoll R, Flood D, et al. Concentration-response relationship of the alpha7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Biochem Pharmacol. 2015;97:576–89.CrossRefPubMed
27.
Neligan A, Walker MC. Initial treatment of nonconvulsive status epilepticus. In: Drislane F, Kaplan MP, editors. Status epilepticus current clinical neurology. Cham: Springer; 2018. p. 275–82.CrossRef
28.
Nimmrich V, Draguhn A, Axmacher N. Neuronal network oscillations in neurodegenerative diseases. NeuroMolecular Med. 2015;17:270–84.CrossRefPubMed
29.
Dauwels J, Vialatte F, Cichocki A. Diagnosis of Alzheimer's disease from EEG signals: where are we standing? Curr Alzheimer Res. 2010;7:487–505.CrossRefPubMed
30.
Gurevicius K, Lipponen A, Tanila H. Increased cortical and thalamic excitability in freely moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease. Cereb Cortex. 2013;23:1148–58.CrossRefPubMed
31.
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016;17:777–92.CrossRefPubMed
32.
Goutagny R, Gu N, Cavanagh C, Jackson J, Chabot JG, Quirion R, et al. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci. 2013;37:1896–902.CrossRefPubMed
33.
Sammer G, Blecker C, Gebhardt H, Bischoff M, Stark R, Morgen K, et al. Relationship between regional hemodynamic activity and simultaneously recorded EEG-theta associated with mental arithmetic-induced workload. Hum Brain Mapp. 2007;28:793–803.CrossRefPubMed
34.
Axmacher N, Henseler MM, Jensen O, Weinreich I, Elger CE, Fell J. Cross-frequency coupling supports multi-item working memory in the human hippocampus. Proc Natl Acad Sci U S A. 2010;107:3228–33.CrossRefPubMedPubMedCentral
35.
McNaughton N, Kocsis B, Hajós M. Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function? Behav Pharmacol. 2007;18:329–46.CrossRefPubMed
36.
Stoiljkovic M, Kelley C, Nagy D, Hajós M. Modulation of hippocampal neuronal network oscillations by α7 nACh receptors. Biochem Pharmacol. 2015;97:445–53.CrossRefPubMed
37.
Vandecasteele M, Varga V, Berenyi A, Papp E, Bartho P, Venance L, et al. Optogenetic activation of septal cholinergic neurons suppresses sharp wave ripples and enhances theta oscillations in the hippocampus. Proc Natl Acad Sci U S A. 2014;111:13535–40.CrossRefPubMedPubMedCentral
38.
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats. Eur J Pharmacol. 1999;380:101–7.CrossRefPubMed
39.
Ballinger EC, Ananth M, Talmage DA, Role LW. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron. 2016;91:1199–218.CrossRefPubMedPubMedCentral
40.
41.
Nathan PJ, Baker A, Carr E, Earle J, Jones M, Nieciecki M, et al. Cholinergic modulation of cognitive function in healthy subjects: acute effects of donepezil, a cholinesterase inhibitor. Hum Psychopharmacol. 2001;16:481–3.CrossRefPubMed
42.
Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;61:473–81.CrossRefPubMed
43.
Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer's disease: causes and clinical relevance. Lancet Neurol. 2017;16:311–22.CrossRefPubMedPubMedCentral
44.
Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci. 2009;29:3453–62.CrossRefPubMed
45.
Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007;55:697–711.CrossRefPubMed
46.
Buzsáki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci. 1988;8:4007–26.CrossRefPubMed
47.
Radek RJ, Curzon P, Decker MW. Characterization of high voltage spindles and spatial memory in young, mature and aged rats. Brain Res Bull. 1994;33:183–8.CrossRefPubMed
48.
Shaw FZ. 7-12 Hz high-voltage rhythmic spike discharges in rats evaluated by antiepileptic drugs and flicker stimulation. J Neurophysiol. 2007;97:238–47.CrossRefPubMed
49.
Riekkinen P Jr, Riekkinen M, Sirvio J, Miettinen R, Riekkinen P. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits. Neuroscience. 1992;47:823–31.CrossRefPubMed
50.
Killory BD, Bai X, Negishi M, Vega C, Spann MN, Vestal M, et al. Impaired attention and network connectivity in childhood absence epilepsy. NeuroImage. 2011;56:2209–17.CrossRefPubMedPubMedCentral
51.
Bentley P, Driver J, Dolan RJ. Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain. 2008;131:409–24.CrossRefPubMed
52.
Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, et al. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005;76:315–9.CrossRefPubMedPubMedCentral
53.
Brassen S, Adler G. Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry. 2003;36:304–8.CrossRefPubMed
54.
Reeves RR, Struve FA, Patrick G. The effects of donepezil on quantitative EEG in patients with Alzheimer's disease. Clin Electroencephalogr. 2002;33:93–6.CrossRefPubMed
55.
Jones RW. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease? Int J Geriatr Psychiatry. 2003;18:S7–S13.CrossRefPubMed
56.
Babiloni C, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, et al. Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: responders vs. non-responders. NeuroImage. 2006;31:1650–65.CrossRefPubMed
57.
Buzsáki G, Draguhn A. Neuronal oscillations in cortical networks. Science. 2004;304:1926–9.CrossRef
58.
Wirsich J, Rey M, Guye M, Benar C, Lanteaume L, Ridley B, et al. Brain networks are independently modulated by donepezil, sleep, and sleep deprivation. Brain Topogr. 2018;31:380–91.CrossRefPubMed
59.
60.
Knight R, Khondoker M, Magill N, Stewart R, Landau S. A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord. 2018;45:131–51.CrossRefPubMed
Metadata
Title
Neurophysiological signals as predictive translational biomarkers for Alzheimer’s disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats
Authors
Milan Stoiljkovic
Craig Kelley
Tamas L. Horvath
Mihály Hajós
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Alzheimer's Research & Therapy / Issue 1/2018
Electronic ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-018-0433-4

Other articles of this Issue 1/2018

Alzheimer's Research & Therapy 1/2018 Go to the issue

Research

Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study

Research

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Research

Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates

Viewpoint

“Exceptional brain aging” without Alzheimer’s disease: triggers, accelerators, and the net sum game

Research

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

Research

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network